Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD | Zendy

H Magnussen | Zendy; Bernd Disse | Zendy; Roberto Rodríguez-Roisin | Zendy; Anne Kirsten | Zendy; Henrik Watz | Zendy; Kay Tetzlaff | Zendy; Lesley Towse | Zendy; Helen Finnigan | Zendy; Ronald Dahl | Zendy; Marc Decramer | Zendy; Pascal Chanez | Zendy; Emiel F.�M. Wouters | Zendy; Peter M.A. Calverley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

Author(s) -

H Magnussen,

Bernd Disse,

Roberto Rodríguez-Roisin,

Anne Kirsten,

Henrik Watz,

Kay Tetzlaff,

Lesley Towse,

Helen Finnigan,

Ronald Dahl,

Marc Decramer,

Pascal Chanez,

Emiel F.�M. Wouters,

Peter M.A. Calverley

Publication year - 2014

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1407154

Subject(s) - medicine , copd , fluticasone propionate , fluticasone , exacerbation , glucocorticoid , salmeterol , hazard ratio , confidence interval , indacaterol , inhalation , anesthesia , bronchodilator , asthma

Treatment with inhaled glucocorticoids in combination with long-acting bronchodilators is recommended in patients with frequent exacerbations of severe chronic obstructive pulmonary disease (COPD). However, the benefit of inhaled glucocorticoids in addition to two long-acting bronchodilators has not been fully explored.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research